These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9256714)

  • 1. GM-CSF in the treatment of skin ulceration in breast cancer.
    Wandl UB
    J Wound Care; 1997 Apr; 6(4):165-6. PubMed ID: 9256714
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing.
    El-Saghir N; Otrock Z; Mufarrij A; Abou-Mourad Y; Salem Z; Shamseddine A; Abbas J
    Lancet Oncol; 2004 May; 5(5):320-1. PubMed ID: 15120669
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.
    Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T
    Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of GM-CSF (granulocyte macrophage colony stimulating factor) on doxorubicin induced tissue necrosis and wound healing.
    Eroglu E; Sari A; Altuntas I; Delibas N; Candir C; Agalar F
    Indian J Cancer; 2000 Dec; 37(4):153-7. PubMed ID: 12018567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of non-healing ulcers with rhGM-CSF and skin grafts.
    Pojda Z; Struzyna J
    Lancet; 1994 Apr; 343(8905):1100. PubMed ID: 7909116
    [No Abstract]   [Full Text] [Related]  

  • 6. Pressure ulcer accelerated healing with local injections of granulocyte macrophage-colony stimulating factor.
    El Saghir NS; Bizri AR; Shabb NS; Husami TW; Salem Z; Shamseddine AI
    J Infect; 1997 Sep; 35(2):179-82. PubMed ID: 9354355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Application of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients with Wounds.
    Brem H; Howell R; Criscitelli T; Senderowicz A; Siegart N; Gorenstein S; Gillette B
    Surg Technol Int; 2018 Jun; 32():61-66. PubMed ID: 29611156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerated haemangioma successfully treated with interferon alfa-2b and topical granulocyte-macrophage colony-stimulating factor.
    Illum N; Karlsmark T; Svejgaard E; Ullman S; Yssing M
    Dermatology; 1995; 191(4):315-7. PubMed ID: 8573929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing.
    Ure I; Partsch B; Wolff K; Petzelbauer P
    Br J Dermatol; 1998 Feb; 138(2):277-82. PubMed ID: 9602874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.
    Mamounas EP; Anderson S; Wickerham DL; Clark R; Stoller R; Hamm JT; Stewart JA; Bear HD; Glass AG; Bornstein R
    Am J Clin Oncol; 1994 Oct; 17(5):374-81; discussion 382. PubMed ID: 7522393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer.
    Cho SG; Park YM; Moon H; Kim KM; Bae SS; Kim GB; Cho HS; Kim CC; Lee KS
    J Korean Med Sci; 1998 Dec; 13(6):685-8. PubMed ID: 9886182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy.
    Rovirosa A; Ferre J; Biete A
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):747-54. PubMed ID: 9652834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
    Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing.
    Jyung RW; Wu L; Pierce GF; Mustoe TA
    Surgery; 1994 Mar; 115(3):325-34. PubMed ID: 7510423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
    Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice.
    Fang Y; Gong SJ; Xu YH; Hambly BD; Bao S
    Br J Dermatol; 2007 Sep; 157(3):458-65. PubMed ID: 17553038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF and wound healing.
    Wheeler G; Brodie GN
    Med J Aust; 1998 Jun; 168(11):580. PubMed ID: 9640310
    [No Abstract]   [Full Text] [Related]  

  • 20. Granulocyte macrophage-colony stimulating factor for treatment of chemotherapy extravasation.
    Shamseddine AI; Khalil AM; Kibbi AG; Abu Nasr TA; Seoud MA; El Saghir NS
    Eur J Gynaecol Oncol; 1998; 19(5):479-81. PubMed ID: 9863917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.